The Valley Desk

NCT02443077 · Interventional trial

Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Overall registry status Active not recruiting

Phase 3

Conditions Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov